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Abstract
Background: Post-myocardial depression is a highly prevalent condition which worsens the course 
and prognosis of coronary artery disease. One possible pathogenetic factor is dysregulation of the 
hypothalamic-pituitary-adrenal axis, resulting in cortisol profile disturbances. 
Methods: Thirty seven patients hospitalized due to a first myocardial infarction (MI) were enrolled in 
this study. The Beck Depression Inventory (BDI) was used to rate the severity of their depressive symp-
toms. Morning and afternoon serum cortisol samples were taken on the fifth day of the MI.
Results: Depression, defined as BDI ≥ 10, was present in 34.4% of the patients. A statistically  
significant difference was observed between the mean morning and the evening plasma concentrations 
in  patients with depression compared to the no-depression group: F (1.29) = 5.0405, p = 0.0328.
Conclusions: Patients with depressive symptoms directly after MI have a flattened diurnal serum 
cortisol profile. This is particularly expressed in patients with longer lasting symptoms. (Cardiol J 2019; 
26, 5: 550–554)
Key words: depression, myocardial infarction, cortisol, hypothalamic pituitary  
adrenal axis
Introduction
Approximately 1 in 5 patients after myocardial 
infarction (MI) develop depression during their ini-
tial hospitalization [1]. Depending on the diagnostic 
method and criteria used, the prevalence of post-MI 
depression varies from 7.2% to 47%.
The pathogenesis of post-MI depression is 
complex. Apart from psychological and psychoso-
cial factors, biological elements play a significant 
role. They include immune, endocrine, autonomous 
and nutritional aspects [2–5]. Post MI depression 
can be defined as an “acute sickness response” 
triggered by MI [6]. This response includes the 
activation of proinflammatory cytokines, the au-
tonomous nervous system and hypothalamic-
pituitary-adrenal (HPA) axis, which in some cases 
may prolong dysregulation in these systems. One 
of the effects of this dysregulation is probably the 
selective dysfunction of the prefrontal cortex and 
anterior cingulate gyrus, precipitating depressive 
symptoms [7]. Studies involving the immune and 
endocrine (mainly HPA axis) profiles in patients 
with post-MI depression may elucidate the patho-
physiology of post-MI depression and its effect 
on the course and prognosis of the condition in 
patients after MI [7]. Unfortunately there remain 
very few studies in this area.
The aim of this study was to evaluate morning 
and afternoon serum cortisol concentrations as 
parameters of the HPA axis function in pa- 
tients with depression after MI. The comparison 
group was composed of patients after MI without 
depression.
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Methods
Thirty-seven patients (8 women; 22%) admit-
ted to the First Cardiology Department at the Medi-
cal University of Gdansk were enrolled, 32 patients 
completed the study. They were hospitalized due 
to a first myocardial infarction with ST elevation 
(STEMI). The left ventricular ejection fraction 
(LVEF) was ≥ 40%, and mean body mass index 26.9 
kg/m2. All patients had a cardiovascular interven-
tion and received standard pharmacological treat-
ment. Exclusion criteria were endocrine diseases 
such as diabetes, hypo- or hyperthyroidism, severe 
renal or hepatic failure, hormone therapy, active 
addiction to psychoactive substances and the pres-
ence of psychiatric disorders other than depression.
The study was approved by the Independent 
Ethics Committee of the Medical University of 
Gdansk (approval number NKEBN/205/2006). For 
each participant written consent was obtained.
All patients were diagnosed with the Struc-
tured Clinical Interview for DSM-IV Axis I Dis-
orders [8] and rated with the Beck Depression 
Inventory (BDI) [9]. The evaluation took place 
3 times over a 6 month period: on the fifth day 
(during the first 5 days) and on the third and sixth 
month after MI. Medical history of 9 patients 
revealed depression in the past — none of them 
suffered from the disorder directly before MI. All 
patients included in the depression group met the 
criteria of post-MI depression.
Blood samples for cortisol analysis were 
collected on the fifth day of the MI twice. First 
between 8 and 10 am and later between 3 and 
5 pm. Both times, two samples were taken at least 
20 min apart: two samples in the morning and two 
samples in the afternoon. The blood was centri-
fuged immediately and the serum was frozen at 
–80oC for batch analysis.
The cortisol concentration was measured with 
a chemiluminescent microparticle immunoassay 
(CIMA) for the quantitative determination of cor-
tisol in the human serum, on the Architect system 
(Architect®, Abbott, DE) kit. The intra-assay coef-
ficient of variation (CV) ranged from 2.1% to 5.5% 
and total CV values ranged from 2.5% to 7.7%. 
The sensitivity was 22.07 nmol/l (0.8 µg/dL). The 
cortisol concentration units were nmol/L and the 
result was an average of two measurements. All 
protocol requirements (6-month observation, 
complete blood sampling) being fulfilled, 32 pa-
tients (including 7 women — 22%) qualified for 
further analysis. These patients were divided into 
two groups depending on their BDI score on the 
fifth day after MI: < 10 (non-depressed) and ≥ 10 
(depressed). 
Statistical analysis
Statistical analysis was performed with the use 
of Statistica v.12.5.1920 and StatsDirect v.3.0.183. 
Depending on the distribution (Wilk-Shapiro test), 
comparison was done with the help of the Stu-
dent t-test or Mann-Whitey U test. ANOVA with 
repeated measures was used when the changes 
between the morning and afternoon cortisol levels 
were compared between the two groups. All tests 
were two-tailed with an alpha = 0.05.
Results
Demographic, clinical and hormonal character-
istics of the two groups are presented in Table 1.
There were no differences in the morning 
and afternoon cortisol concentrations between 
depressed and non-depressed groups (Table 1).
The changes of cortisol levels between the 
morning and afternoon in the two groups are shown 
in Figure 1. A statistically significant difference was 
found between the groups (ANOVA with repeated 
measurement).
Post-hoc analysis (Bonferroni test) showed 
a significant difference between the morning and 
afternoon cortisol levels only in the non-depressed 
group (p = 0.0004). The presence of depressive 
episodes in the past did not change these results 
(F = 5.04, p = 0.0328 ANOVA with repeated 
measures).
No differences in cortisol concentrations 
were observed between women (n = 6) and men 
(n = 7) in the depressed group (F(1.9) = 0.067, 
p = 0.8019). 
No significant differences between morning 
and afternoon levels of cortisol were found in both 
subgroups based on the length of depression. The 
longer lasting depression group (≥ 3 months) dif-
fered significantly from the no depression group in 
the morning and afternoon ratio (Table 2)
In the depression group (BDI ≥ 10), patients 
with the diagnosis of major depression (n = 4) did 
not differ in their cortisol concentrations from the 
rest of depression group patients (n = 7) (unpaired 
t-test).
Discussion
In this study the BDI was used to measure 
depression. The cut-off score of 10 was used to dif-
ferentiate between depressed and non-depressed 
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patients. It is this criterion that is most commonly 
used in post-myocardial depression studies. Many 
studies have shown that depression as defined by 
a BDI ≥ 10 is related to increased cardiovascular 
risk, including death [10–14]. 
A BDI score ≥ 10 was observed in 11 (34.4%) 
patients. Four (12.5%) patients met criteria of hav-
ing suffered a major depressive episode according 
to DSM-IV-TR. These data correspond with other 
studies [1, 10, 11].
An immediate increase in cortisol after MI 
has been previously reported [15, 16]. In the 
(aforementioned) studies cortisol concentration 
normalised during the first 72 h after MI. In the 
present study, serum cortisol was measured on 
the fifth day of MI. Morning as well as afternoon 
concentrations did not exceed physiological val-
ues. The depressed and non-depressed groups 
did not differ from each other in either morning 
or afternoon cortisol concentration, which is in 
line with the results published by Whitehead et al. 
[17]. However, a significant difference was found 
in the diurnal profile (morning–afternoon) of the 
cortisol level between these two groups. The 
non-depressed group showed a normal cortisol 
secretion rhythm; the morning cortisol level was 
significantly higher than the afternoon level. Such 
a significant difference was not recorded in the de-
Table 1. Demographic and clinical variables.
All patients Beck Depression Inventory (BDI)
≥ 10 < 10
N 32 11 (34.4%) 21 (65.6%)
Women 7 (22%) 6 (55%) 1 (5%)
Age [years]# 54.7 (51.9, 57.5) 53.4 (47.0, 59.7) 55.4 (52.3, 58.5)
Weight [kg]# 81.2 (75.4, 87.0) 80.0 (68.2, 91.8) 81.8 (74.7, 88.9)
Body mass index [kg/m2]# 26.9 (25.5, 28.3) 25.5 (23.1, 27.9) 27.6 (25.8, 29.4) 
Tail circumference [cm]# 96.2 (92.1, 100.2) 94.2 (85.7, 102.7) 97.3 (92.5, 102.1) 
Waist to hip ratio# 0.96 (0.93, 0.98) 0.95 (0.89, 1.00) 0.96 (0.93, 0.99) 
Depression in the past 9 5 4 
BDI score (3rd day)## 5 (1, 12) 14* (12, 21) 2 (1, 5)
BDI (3rd month)##  Incidence 6 6 0
BDI (6th day)##  Incidence 3 2 1
Major depressive disorder (DSM IV-TR)+ 4 4 0
Morning plasma cortisol level [nmol/L]# 366.3** (327.7, 404.8) 368.8 (299.1, 438.4) 364.9*** (314.4, 415.5) 
Afternoon plasma cortisol level [nmol/L]# 292.8 (245.3, 340.4) 351.6 (261.5, 441.6) 262.0 (206.1, 317.9)
Morning/afternoon cortisol ratio# 1.55 (1.32, 1.78) 1.21 (0.94, 1.49) 1.73**** (1.42, 2.03)
+DSM IV-TR — Diagnostic and Statistica Manual of Mental Disorders Fourth Edition Text Revision
#mean (95% confidence interval [CI])
##median (interquartile range)
*vs. group (< 10): p < 0.0001; Mann-Whitney U test, difference between medians = 12 (9, 17) 
**vs. afternoon cortisol: p = 0.0006; paired t-test, difference between means (95% CI) = 73.4 (34.5, 112.3) 
***vs. afternoon cortisol: p = 0.0001 paired t-test, difference between means (95% CI) = 102.9 (57.9, 148.0)
****vs. group (≥ 10): p = 0.0228; Student’s t-test, mean of differences (95% CI) = 0.34 (0.06, 0.97)
Figure 1. Diurnal change of plasma cortisol level and 
the presence of depression (Beck Depression Inventory 
≥ 10): ANOVA with repeated measures.
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pressed group, which suggests that flattened daily 
rhythm of cortisol is more expressed in patients 
with a longer (≥ 3 months) duration of depression. 
According to available research there have 
been no previous studies on diurnal cortisol profile 
in patients with depression shortly after MI.
These observations may have important clini-
cal implications. A flattening of the diurnal rhythm 
of cortisol has been observed in young patients 
with major depressive disorder [18] and in adoles-
cence patients after major depression [19]. This 
had a negative impact on health [20]. In a healthy 
population it is connected with a decline in cogni-
tive functions [21] which could lead to a lowered 
ability in dealing with stress. 
The absence of normal cortisol diurnal rhythm 
in the present post-infarct depression group could 
influence abilities in dealing with stress and, as 
a result, maintain depressive symptoms and in-
crease the risk of somatic complications. In the 
presented study patients with longer depression 
(lasting at least 3 months) had a particularly low 
morning to afternoon cortisol concentration ratio. 
A flatter diurnal rhythm of cortisol secretion has 
been observed before in patients with coronary 
artery disease (CAD) who scored ≥ 10 points in 
BDI [22].
A flatter diurnal cortisol slope is related to 
a worse prognosis in patients after coronary ar-
tery bypass graft surgery [23], and it can be also 
responsible for the progression of atherosclerosis 
in patients with depression and CAD [24]. No 
somatic complications were observed in either 
the depressed or non-depressed group during 
the 6-month study. The interrelations however, 
between post-MI depression, the course of CAD 
and diurnal cortisol rhythm disturbance needs 
further study.
Limitations of the study
This study has a number of limitations. Firstly, 
the study group is quite small. Secondly, cortisol 
concentration was only tested on 1 day. Additional 
samples on subsequent visits after 3 and 6 months, 
could broaden interpretation of the results. Thirdly, 
to some extent, the lack of a control group is also 
a limitation, although the aim of this study was 
to determine the cortisol profile in patients with 
depression compared to patients without depres-
sion on the fifth day after MI. Another shortcoming 
is the small number of women in the study group 
(22%) and the imbalance between the number of 
women in the depressed (6) and the non-depressed 
group (1). Preliminary findings of this study need 
further confirmation in  larger groups with com-
parisons to healthy controls. 
Conclusions
The presence of depressive symptoms (BDI 
≥ 10) directly after MI is related to a flattening of 
the diurnal serum cortisol profile. This seems to be 
expressed particularly in patients with longer lasting 
(≥ 3 months) depression.
Table 2. Clinical variables and length of depression (BDI ≥ 10) 
Presence of depression (BDI ≥ 10) after myocardial infarction
NO {1} ≥ 3 months {2} < 3 months {3}
N 21 (65.6%) 6 (18.8%) 5 (15.6%)
BDI score (3rd day)## 2 (1, 5) 14* (12, 18) 15** (11, 21)
BDI score (3rd month)## 3 (1, 5) 12*** (12, 14) 4 (4, 6)
BDI score (6th day)## 2.5 (1, 5) 10& (8, 12) 3.0 (3, 5)
Major depressive episode (DSM IV-TR)+ 0 3 1
Morning plasma cortisol level [nmol/L]# 364.9&& (314.4, 415.5) 353.0 (348.3, 457.7) 387.7 (242.9, 532.5) 
Afternoon plasma cortisol level [nmol/L]# 262.0 (206.1, 317.9) 344.8 (239.2, 450.5) 359.7 (137.3, 582.2)
Morning/afternoon cortisol ratio# 1.73 (1.42, 2.03) 1.07&&& (0.66, 1.48) 1.38 (0.89, 1.88)
+DSM IV-TR — Diagnostic and Statistica Manual of Mental Disorders Fourth Edition Text Revision
#mean (95% confidence interval [CI])
##median (interquartile range)
*vs. group {1}: p = 0.00001; Mann-Whitney U test 12 (9, 17)
**vs. group {1}: p = 0.00003; Mann-Whitney U test 12 (8, 20)
***vs. group {1}: p = 0.00004; Mann-Whitney U test (95% CI) = 10 (7, 14); {3}: p = 0.008; Mann-Whitney U test (95% CI) = 8 (4, 17)
&vs. group {1}: p = 0.002; Mann-Whitney U test (95% CI) = 7 (3, 10); {3}: p = 0.016; Mann-Whitney U test (95% CI) = 6 (2, 10)
&&vs. afternoon cortisol: p = 0.0001; paired t-test (95% CI) = 102.9 (57.9, 148.0)
&&&vs. group {1}: p = 0.0331; Student’s t-test (95% CI) = –0.31 (–1.25, –0.06)
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